165 related articles for article (PubMed ID: 18834983)
1. Acute arterial thrombosis in the absence of inflammation: the stress-related anti-inflammatory hormone ACTH participates in platelet-mediated thrombosis.
Pozzi AO; Bernardo E; Coronado MT; Punchard MA; González P; Fantidis P
Atherosclerosis; 2009 May; 204(1):79-84. PubMed ID: 18834983
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
3. Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.
Dai J; Louedec L; Philippe M; Michel JB; Houard X
J Vasc Surg; 2009 Mar; 49(3):719-27. PubMed ID: 19028049
[TBL] [Abstract][Full Text] [Related]
4. Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
Huang J; Driscoll EM; Gonzales ML; Park AM; Lucchesi BR
J Pharmacol Exp Ther; 2000 Nov; 295(2):492-9. PubMed ID: 11046080
[TBL] [Abstract][Full Text] [Related]
5. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
Packham MA; Mustard JF
Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
[TBL] [Abstract][Full Text] [Related]
6. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
[TBL] [Abstract][Full Text] [Related]
7. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
Iyú D; Glenn JR; White AE; Fox SC; Dovlatova N; Heptinstall S
Platelets; 2011; 22(7):504-15. PubMed ID: 21591981
[TBL] [Abstract][Full Text] [Related]
8. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
[TBL] [Abstract][Full Text] [Related]
9. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
11. Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery.
Arazi HC; Doiny DG; Torcivia RS; Grancelli H; Waldman SV; Nojek C; Fornari MC; Badimon JJ
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):863-7. PubMed ID: 20233808
[TBL] [Abstract][Full Text] [Related]
12. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation.
Kim K; Bae ON; Lim KM; Noh JY; Kang S; Chung KY; Chung JH
J Pharmacol Exp Ther; 2012 Dec; 343(3):704-11. PubMed ID: 22984226
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointima.
Patil SB; Jackman LE; Francis SE; Judge HM; Nylander S; Storey RF
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2385-91. PubMed ID: 21071697
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy.
Obi C; Wysokinski W; Karnicki K; Owen WG; McBane RD
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1271-6. PubMed ID: 19667107
[TBL] [Abstract][Full Text] [Related]
15. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis.
Evans DJ; Jackman LE; Chamberlain J; Crosdale DJ; Judge HM; Jetha K; Norman KE; Francis SE; Storey RF
Circulation; 2009 Jan; 119(1):116-22. PubMed ID: 19103996
[TBL] [Abstract][Full Text] [Related]
16. A new role for the A2b adenosine receptor in regulating platelet function.
Yang D; Chen H; Koupenova M; Carroll SH; Eliades A; Freedman JE; Toselli P; Ravid K
J Thromb Haemost; 2010 Apr; 8(4):817-27. PubMed ID: 20102488
[TBL] [Abstract][Full Text] [Related]
17. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
Rozalski M; Nocun M; Watala C
Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
[TBL] [Abstract][Full Text] [Related]
18. MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice.
Hechler B; Nonne C; Roh EJ; Cattaneo M; Cazenave JP; Lanza F; Jacobson KA; Gachet C
J Pharmacol Exp Ther; 2006 Feb; 316(2):556-63. PubMed ID: 16236815
[TBL] [Abstract][Full Text] [Related]
19. Endogenous anti-inflammatory response after coronary injury in a porcine model.
Fantidis P; Pérez De Prada T; Fernández-Ortiz A; Sanmartín M; Alfonso F; Hernández R; Escaned J; Bañuelos C; Sabaté M; Macaya C
Eur J Clin Invest; 2001 Dec; 31(12):1019-23. PubMed ID: 11903486
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]